Affiliated Treatment Facilities
Contact Information
Thoracic/Head and Neck Medical Oncology Dept., Unit 432
1400 Holcombe Boulevard
Houston, TX 77030
01. Doctor Overview
Doctor Overview
As director of the mesothelioma program at the M.D. Anderson Cancer Center at the University of Texas in Houston, Anne Tsao M.D. is one of the nation’s foremost authorities on malignant mesothelioma.
Dr. Tsao and her colleagues at Anderson have penned many articles providing a large amount of information for many professional journals and have been involved in numerous clinical trials involving the treatment of malignant mesothelioma, an aggressive form of cancer that is often diagnosed in advanced stages and difficult to treat.
In articles in publications such as the Journal of Clinical Oncology, Tsao has discussed the impact of novel therapies, the importance of clinical trials, and controversial issues such as the use of extrapleural pneumonectomy in the treatment of the disease. She has also campaigned for the use of intrapleural therapies as well as gene therapy and immunotherapy for the treatment of malignant pleural mesothelioma and lectures nationally and internationally on these subjects.
Tsao has also performed studies involving smoking history and its impact on the prognosis of those with non-small cell lung cancers like mesothelioma. She has also stressed the need for chemo-prevention, the use of natural, synthetic, or biologic chemical agents to suppress cancer in high-risk populations or prevent carcinogenic progression to invasive cancer.
02. Fast Facts
Doctor Fast Facts
Main Specialty: Thoracic Medical Oncology
Other Interests & Specialties: Individualized cancer therapy, mesothelioma and lung cancer.
Certifications, Awards & Accolades: Co-Chair of the MDACC Clinical Research Committee, Scientific Advisory Committee member, chairing session participant for American Radium Society, Chair of the Communications Committee for International Association for the Study of Lung Cancer (IASLC), Chair of the Mesothelioma Applied Research Foundation (MARF), SWOG Executive Lung Committee member, SWOG Mesothelioma Steering Committee member, DSMB for NRG Thoracic Oncology member, NRG Lung Executive Committee member
Education & Experience:
- Internship and Residency at Indiana University
- Medical Oncology Fellowship at the University of Texas MDACC
- Medical Degree from the University of Chicago Pritzker School of Medicine
03. Publications
Publications
Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. September 2016. doi: 10.1200/JCO.2005.02.477
Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). BioMed Central Ltd. in Head & Neck Oncology. June 2010;2(1):15. doi: 10.1186/1758-3284-2-1-15
04. Mesothelioma Clinical Trials
Mesothelioma Clinical Trials by Anne S. Tsao, M.D.
Dr. Tsao is associated with the following clinical trials:
Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: January 27, 2022
Status: Active, not recruiting
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: January 22, 2022
Status: Active, not recruiting
Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: June 15, 2021
Status: Active, not recruiting
Phase II Study of Adjuvant WT-1 Analog Peptide Vaccine in MPM Patients After MSK10-134
Conditions: Mesothelioma
Last Updated: May 9, 2019
Status: Active, not recruiting
Unfortunately we were not able to locate any active mesothelioma clinical trials in . Clinical Trials are important for exploring new treatment options and improving patient outcomes. You may, however, be able to find clinical trials focusing on mesothelioma in other states.
Here are some other sites that might help you locate mesothelioma-specific clinical trials:
- National Cancer Institute (NCI) Clinical Trials Database - NCI provides a comprehensive list of clinical trials across the U.S. Trials can be searched for based on location, treatment type, and eligibility.
- ClinicalTrials.gov - This web site hosts the U.S. government’s database for clinical trials. You can find specific mesothelioma trials by searching with relevant keywords, such as "mesothelioma," "asbestos-related cancer," or "pleural mesothelioma."
- Mesothelioma Applied Research Foundation (MARF): The MARF foundation funds mesothelioma research and might have information on current trials.
